Lexeo Therapeutics, Inc. (LXEO) Equity Ratio (2022 - 2023)
Lexeo Therapeutics' Equity Ratio history spans 2 years, with the latest figure at 2.98 for Q3 2023.
- For Q3 2023, Equity Ratio changed N/A year-over-year to 2.98; the TTM value through Sep 2023 reached 2.98, changed N/A, while the annual FY2022 figure was 1.16, N/A changed from the prior year.
- Equity Ratio for Q3 2023 was 2.98 at Lexeo Therapeutics, down from 1.16 in the prior quarter.
- Across five years, Equity Ratio topped out at 1.16 in Q4 2022 and bottomed at 2.98 in Q3 2023.